Government officials and global experts from the medical, financial, and legal sectors gathered in Hong Kong on Monday to discuss making the city a regional intellectual property trading center for cancer technology.

The discussions took place at the first 2025 Hong Kong Global Cancer IP Investors Forum.

“Hong Kong is steadily evolving into a regional IP trading hub, leveraging its financial system, legal framework, and international research network,” Hong Kong Deputy Financial Secretary Michael Wong Wai-lun said at the forum’s opening ceremony.

READ MORE: Forum: HK well positioned to contribute to IP landscape

By enhancing the collaboration through nongovernmental commercial, academic, and cultural exchanges, “this forum not only underscores Hong Kong’s role as a superconnector but also injects fresh momentum into the global anti-cancer technologies,” Wong said.

Ko Wing-man, chairman of the Global Cancer IP Promotion Alliance (GCIPPA), the forum’s operating organizer, said that the organization’s goal is to bridge the gap between scientific breakthroughs and life-saving applications, acting as an innovation accelerator.

GCIPPA Executive Director Ralph Chow said in a previous interview that with the rapid development of science and technology on the Chinese mainland in recent years, many anti-cancer medical devices were mature in technology with relatively low costs in research and development.

READ MORE: Finance chief: IP protection key to city's innovation drive

“Through Hong Kong’s intellectual-property trade platform, we hope that these devices can be promoted globally, reducing treatment costs and benefiting patients worldwide,” Chow said.

Contact the writer at thor_wu@chinadailyhk.com